SCHEMBL30752565

SCHEMBL30752565

CCN(c1nc(Cl)nc2c(F)c(Br)c(C(F)(F)F)cc12)C1CC(O[Si](C)(C)C(C)(C)C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30752566 1.00 — —
SCHEMBL30752568 1.00 — —
SCHEMBL30752591 0.88 — —
SCHEMBL30752616 0.77 — —
SCHEMBL30752602 0.75 PDE2A (0.34) —
SCHEMBL30752633 0.75 GBA1 (0.33) —
SCHEMBL30752575 0.75 — —
SCHEMBL29222195 0.74 PGR (0.36) —
SCHEMBL30752563 0.73 — —
SCHEMBL31021641 0.71 PIK3CD (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4565579-A1 COMPOSITIONS AND METHODS FOR INHIBITION OF KRAS Theras, Inc. (US) 2025-06-11 — — EP disclosed
Send feedback